| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/13/2011 | EP1789068B1 Composition and use for prevention or treatment of stomatitis |
| 07/13/2011 | EP1778702B1 Antiviral compounds |
| 07/13/2011 | EP1765312B1 Treatment of diseases associated with the use of antibiotics |
| 07/13/2011 | EP1758557B1 Swellable dosage form comprising gellan gum |
| 07/13/2011 | EP1758552B1 Intraocular implants of alpha-2 adrenergic receptor agonists for preventing or reducing ocular vascular occlusions |
| 07/13/2011 | EP1755576B1 Antimicrobial compositions and methods for their use |
| 07/13/2011 | EP1737467B1 Composition for the treatment of skin conditions |
| 07/13/2011 | EP1733723B1 Medicine capable of inhibiting activation of transcription factor klf5 |
| 07/13/2011 | EP1725537B1 Novel compounds as opioid receptor modulators |
| 07/13/2011 | EP1720857B1 Dihydropyridinone derivatives |
| 07/13/2011 | EP1718322B1 Synergistic compositions with fk-228 |
| 07/13/2011 | EP1701699B1 Pharmaceutical compositions of an A2a receptor antagonist |
| 07/13/2011 | EP1667655B1 New use, pharmaceutical preparations as well as a process for their production |
| 07/13/2011 | EP1663183B1 Solid pharmaceutical dosage form comprising ritonavir |
| 07/13/2011 | EP1649017B1 Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer |
| 07/13/2011 | EP1620113B1 Topical formulation of ivermectin for the treatment of dermatological conditions |
| 07/13/2011 | EP1610790B1 Anticancer compounds |
| 07/13/2011 | EP1578741B1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 07/13/2011 | EP1562913B1 Substituted quinazolines as antiviral agents, especially against cytomegaloviruses |
| 07/13/2011 | EP1545553B1 Use of alkyl phosphocholines in combination with antitumor medicaments |
| 07/13/2011 | EP1543158B1 Regulated aptamer therapeutics |
| 07/13/2011 | EP1509489B1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 07/13/2011 | EP1486491B1 Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 07/13/2011 | EP1463502B1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 07/13/2011 | EP1442140B1 Antisense modulation of insulin-like growth factor binding protein 5 expression |
| 07/13/2011 | EP1432420B1 Benzimidazolidinone derivatives as muscarinic agents |
| 07/13/2011 | EP1367886B1 Scce transgenic mice and their use as models of human disease |
| 07/13/2011 | EP1265878B1 A process for the preparation of epothilone analogs and intermediates |
| 07/13/2011 | EP1259478B1 Covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids functionally active on the cb2 cannabinoid receptor |
| 07/13/2011 | EP1181001B1 Sunscreen composition containing sol-gel microcapsules |
| 07/13/2011 | EP1178796B1 Orazamide orotate for the prevention of liver damage |
| 07/13/2011 | EP0979080B1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/13/2011 | CN201894448U Cervical vertebra recovering pillow |
| 07/13/2011 | CN1989104B Cyclic amide derivatives, and their production and use as antithrombotic agents. |
| 07/13/2011 | CN1960759B Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 07/13/2011 | CN1957938B Effervescence tablet of Glucurolactone, and preparation method |
| 07/13/2011 | CN1919249B Chinese traditional medicine for treating cardiovascular and cerebrovascular disease |
| 07/13/2011 | CN1919245B Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 07/13/2011 | CN1919242B Traditional Chinese medicine composition for treating cardiac and cerebral vascular disease |
| 07/13/2011 | CN1903846B Ornidazole derivative used for therapy, its preparation method and use |
| 07/13/2011 | CN1903176B Dry suspensoid of Repirinast and its prepn. method |
| 07/13/2011 | CN1902193B Quinoxalines useful as inhibitors of protein kinases |
| 07/13/2011 | CN1897922B Process for producing pellets for pharmaceutical compositions |
| 07/13/2011 | CN1883599B Chinese medicinal composition for treating women's episioitis or colpitis and method for preparing same |
| 07/13/2011 | CN1867562B Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 07/13/2011 | CN1826338B Therapeutic agent for senile dementia |
| 07/13/2011 | CN1353609B Amide substituted imidazoquinolines |
| 07/13/2011 | CN1175976B Arachidonic acid and method for production and use thereof |
| 07/13/2011 | CN102124122A Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells |
| 07/13/2011 | CN102124108A Use of EIF-5A1 SIRNA to protect islets cells from apoptosis and to preserve their functionality |
| 07/13/2011 | CN102124104A Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl tRNA synthetase |
| 07/13/2011 | CN102124076A Fluorescent compounds for the diagnosis of infections, production method, and applications thereof |
| 07/13/2011 | CN102124032A Process for producing glycosaminoglycans |
| 07/13/2011 | CN102124020A Self-avoiding molecular recognition systems in DNA amplification |
| 07/13/2011 | CN102124012A Macrocyclic indole derivatives useful as hepatitis C virus inhibitors |
| 07/13/2011 | CN102124011A Inhibitors of human immunodeficiency virus replication |
| 07/13/2011 | CN102124010A Isosorbide nitrates having vasodilating activity |
| 07/13/2011 | CN102124009A Kinase inhibitors and methods of use |
| 07/13/2011 | CN102124008A Novel derivatives of pyrroloindole inhibitors of Hsp90, compositions containing same, and use thereof |
| 07/13/2011 | CN102124007A Azacarboline derivatives, preparation method thereof and therapeutic use of same |
| 07/13/2011 | CN102124006A Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
| 07/13/2011 | CN102124005A Cmet inhibitors |
| 07/13/2011 | CN102124004A Azaindole inhibitors of iap |
| 07/13/2011 | CN102124003A Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders |
| 07/13/2011 | CN102124002A Novel phenylimidazole derivatives as pde10a enzyme inhibitors |
| 07/13/2011 | CN102124001A Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 07/13/2011 | CN102124000A Pyridine compounds |
| 07/13/2011 | CN102123998A Isoquinolinone derivatives as nk3 antagonists |
| 07/13/2011 | CN102123995A Phenyl-alkyl piperazines having a modulating activity of tnf |
| 07/13/2011 | CN102123993A Imine derivatives as cannabinoid receptor ligands |
| 07/13/2011 | CN102123992A Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 07/13/2011 | CN102123991A 2 -arylaminoquinazolines for treating proliferative diseases |
| 07/13/2011 | CN102123989A Pyrazole compounds 436 |
| 07/13/2011 | CN102123988A Squaric acid derivatives as inhibitors of the nicotinamide |
| 07/13/2011 | CN102123987A Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 07/13/2011 | CN102123986A Pharmaceutical compositions |
| 07/13/2011 | CN102123980A A process for the preparation of enantiomerically pure amines |
| 07/13/2011 | CN102123763A Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| 07/13/2011 | CN102123736A Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis |
| 07/13/2011 | CN102123735A Agent for induction/maintenance of remission |
| 07/13/2011 | CN102123732A Compositions, methods and kits for eliciting an immune response |
| 07/13/2011 | CN102123716A Compositions and methods for treating viral infections |
| 07/13/2011 | CN102123715A Immune system stimulating nutrition |
| 07/13/2011 | CN102123714A Formulations of canfosfamide and their preparation |
| 07/13/2011 | CN102123713A Sustained release delivery of active agents to treat glaucoma and ocular hypertension |
| 07/13/2011 | CN102123712A Methods of cancer treatment with IGF1R inhibitors |
| 07/13/2011 | CN102123711A Treatment of pulmonary arterial hypertension |
| 07/13/2011 | CN102123710A Bicyclic triazole derivatives for treating tumors |
| 07/13/2011 | CN102123709A A3 adenosine receptor allosteric modulators |
| 07/13/2011 | CN102123708A 8-hydroxyquinoline derivatives for the treatment of hematological malignancies |
| 07/13/2011 | CN102123707A Dabigatran for percutaneous interventional cardiac catheterisation |
| 07/13/2011 | CN102123706A Use of paf receptor for treating infections caused by flaviviridae |
| 07/13/2011 | CN102123705A Dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis, pruritus or combinations of same |
| 07/13/2011 | CN102123704A Organic compounds for wound healing |
| 07/13/2011 | CN102123703A 1-amino-alkylcyclohexane derivatives for the treatment of cognitive impairment in tinnitus |
| 07/13/2011 | CN102123699A Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 07/13/2011 | CN102123698A Carrier nanoparticles and related compositions, methods and systems |
| 07/13/2011 | CN102123588A Substituted imidazole combinations |
| 07/13/2011 | CN102120752A Compound with effects of resisting inflammation and platelet activation and aggregation as well as preparation method and application thereof |
| 07/13/2011 | CN102120751A Nucleoside compound with anti-cancer and anti-virus activities, and preparation method and application thereof |